Current neoadjuvant treatment options for HER2 positive breast cancer
Hikmat Abdel-Razeq, Lina MareiSection of Hematology and Medical Oncology, Department of Internal Medicine, King Hussein Cancer Center, Amman, JordanAbstract: Approximately one quarter of patients with breast cancer demonstrate amplification of the human epidermal receptor type 2 (HER2) gene, the exp...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2011
|
| Subjects: | |
| Online Access: | https://doaj.org/article/fc642340cbf748b88e9d594db1cc3e9c |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|